Aktieanalys

2Curex: Important progress towards compliance with IVD-R - Redeye

Redeye Publicerad: 19 Jul 2021 15:53

Redeye endorses 2cureX getting ISO 13485:2016 certified, signifying a critical milestone towards compliance with EU Regulation 2017/746. As we expected, 2cureX is taking the required steps to comply with the upcoming IVD-R regulation, which is crucial for IndiTreat to remain CE-marked. We are encouraged by the company’s progress, boding well for the ongoing IndiTreat commercialization. By keeping its CE marking for IndiTreat, we believe 2cureX is differentiating itself from competitors. It ensures compliance with the standards that regulators and future clients have for in vitro diagnostic devices.

https://www.redeye.se/research/817353/2curex-important-progress-towards-compliance-with-ivd-r?utm_source=finwire&utm_medium=RSS

Nyheter om 2cureX

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!